vs
AXCELIS TECHNOLOGIES INC（ACLS）与ARDELYX, INC.（ARDX）财务数据对比。点击上方公司名可切换其他公司
AXCELIS TECHNOLOGIES INC的季度营收约是ARDELYX, INC.的2.5倍（$238.3M vs $94.5M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs -39.8%，领先54.2%），ARDELYX, INC.同比增速更快（27.5% vs -5.6%），过去两年ARDELYX, INC.的营收复合增速更高（13.6% vs -2.8%）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
ACLS vs ARDX — 直观对比
营收规模更大
ACLS
是对方的2.5倍
$94.5M
营收增速更快
ARDX
高出33.1%
-5.6%
净利率更高
ACLS
高出54.2%
-39.8%
两年增速更快
ARDX
近两年复合增速
-2.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $94.5M |
| 净利润 | $34.3M | $-37.6M |
| 毛利率 | 47.0% | — |
| 营业利润率 | 15.2% | — |
| 净利率 | 14.4% | -39.8% |
| 营收同比 | -5.6% | 27.5% |
| 净利润同比 | -31.3% | — |
| 每股收益（稀释后） | $1.11 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLSARDX
| Q1 26 | — | $94.5M | ||
| Q4 25 | $238.3M | $125.2M | ||
| Q3 25 | $213.6M | $110.3M | ||
| Q2 25 | $194.5M | $97.7M | ||
| Q1 25 | $192.6M | $74.1M | ||
| Q4 24 | $252.4M | $116.1M | ||
| Q3 24 | $256.6M | $98.2M | ||
| Q2 24 | $256.5M | $73.2M |
净利润ACLSARDX
| Q1 26 | — | $-37.6M | ||
| Q4 25 | $34.3M | $-407.0K | ||
| Q3 25 | $26.0M | $-969.0K | ||
| Q2 25 | $31.4M | $-19.1M | ||
| Q1 25 | $28.6M | $-41.1M | ||
| Q4 24 | $50.0M | $4.6M | ||
| Q3 24 | $48.6M | $-809.0K | ||
| Q2 24 | $50.9M | $-16.5M |
毛利率ACLSARDX
| Q1 26 | — | — | ||
| Q4 25 | 47.0% | 91.3% | ||
| Q3 25 | 41.6% | 96.4% | ||
| Q2 25 | 44.9% | 87.3% | ||
| Q1 25 | 46.1% | 83.4% | ||
| Q4 24 | 46.0% | 84.3% | ||
| Q3 24 | 42.9% | 84.0% | ||
| Q2 24 | 43.8% | 87.1% |
营业利润率ACLSARDX
| Q1 26 | — | — | ||
| Q4 25 | 15.2% | 4.1% | ||
| Q3 25 | 11.7% | 4.2% | ||
| Q2 25 | 14.9% | -14.7% | ||
| Q1 25 | 15.1% | -49.0% | ||
| Q4 24 | 21.6% | 7.0% | ||
| Q3 24 | 18.3% | 2.3% | ||
| Q2 24 | 20.6% | -18.6% |
净利率ACLSARDX
| Q1 26 | — | -39.8% | ||
| Q4 25 | 14.4% | -0.3% | ||
| Q3 25 | 12.2% | -0.9% | ||
| Q2 25 | 16.1% | -19.5% | ||
| Q1 25 | 14.8% | -55.5% | ||
| Q4 24 | 19.8% | 4.0% | ||
| Q3 24 | 18.9% | -0.8% | ||
| Q2 24 | 19.8% | -22.5% |
每股收益（稀释后）ACLSARDX
| Q1 26 | — | $-0.15 | ||
| Q4 25 | $1.11 | $-0.01 | ||
| Q3 25 | $0.83 | $0.00 | ||
| Q2 25 | $0.98 | $-0.08 | ||
| Q1 25 | $0.88 | $-0.17 | ||
| Q4 24 | $1.54 | $0.01 | ||
| Q3 24 | $1.49 | $0.00 | ||
| Q2 24 | $1.55 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | $238.1M |
| 总债务越低越好 | — | $203.5M |
| 股东权益账面价值 | $1.0B | $148.6M |
| 总资产 | $1.4B | $504.5M |
| 负债/权益比越低杠杆越低 | — | 1.37× |
8季度趋势，按日历期对齐
现金及短期投资ACLSARDX
| Q1 26 | — | $238.1M | ||
| Q4 25 | $374.3M | $68.0M | ||
| Q3 25 | $449.6M | $42.7M | ||
| Q2 25 | $549.8M | $90.0M | ||
| Q1 25 | $587.1M | $30.8M | ||
| Q4 24 | $571.3M | $64.9M | ||
| Q3 24 | $579.4M | $47.4M | ||
| Q2 24 | $548.3M | $41.9M |
总债务ACLSARDX
| Q1 26 | — | $203.5M | ||
| Q4 25 | — | $202.8M | ||
| Q3 25 | — | $202.1M | ||
| Q2 25 | — | $201.4M | ||
| Q1 25 | — | $151.3M | ||
| Q4 24 | — | $150.9M | ||
| Q3 24 | — | $100.7M | ||
| Q2 24 | — | $100.2M |
股东权益ACLSARDX
| Q1 26 | — | $148.6M | ||
| Q4 25 | $1.0B | $166.9M | ||
| Q3 25 | $1.0B | $154.3M | ||
| Q2 25 | $1.0B | $139.5M | ||
| Q1 25 | $1.0B | $145.7M | ||
| Q4 24 | $1.0B | $173.3M | ||
| Q3 24 | $975.6M | $158.3M | ||
| Q2 24 | $934.9M | $147.0M |
总资产ACLSARDX
| Q1 26 | — | $504.5M | ||
| Q4 25 | $1.4B | $501.6M | ||
| Q3 25 | $1.4B | $486.2M | ||
| Q2 25 | $1.3B | $466.8M | ||
| Q1 25 | $1.3B | $410.2M | ||
| Q4 24 | $1.3B | $435.8M | ||
| Q3 24 | $1.3B | $367.9M | ||
| Q2 24 | $1.3B | $343.5M |
负债/权益比ACLSARDX
| Q1 26 | — | 1.37× | ||
| Q4 25 | — | 1.21× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | — | 1.44× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | — | 0.87× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | — |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | — |
| 自由现金流率自由现金流/营收 | -3.7% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | $107.0M | — |
8季度趋势，按日历期对齐
经营现金流ACLSARDX
| Q1 26 | — | — | ||
| Q4 25 | $-6.6M | $21.0M | ||
| Q3 25 | $45.4M | $365.0K | ||
| Q2 25 | $39.7M | $-25.3M | ||
| Q1 25 | $39.8M | $-38.5M | ||
| Q4 24 | $12.8M | $9.8M | ||
| Q3 24 | $45.7M | $501.0K | ||
| Q2 24 | $40.1M | $-19.4M |
自由现金流ACLSARDX
| Q1 26 | — | — | ||
| Q4 25 | $-8.9M | $20.6M | ||
| Q3 25 | $43.3M | $209.0K | ||
| Q2 25 | $37.7M | $-26.0M | ||
| Q1 25 | $34.8M | $-38.8M | ||
| Q4 24 | $8.1M | $9.2M | ||
| Q3 24 | $41.8M | $364.0K | ||
| Q2 24 | $38.1M | $-19.5M |
自由现金流率ACLSARDX
| Q1 26 | — | — | ||
| Q4 25 | -3.7% | 16.4% | ||
| Q3 25 | 20.3% | 0.2% | ||
| Q2 25 | 19.4% | -26.6% | ||
| Q1 25 | 18.1% | -52.3% | ||
| Q4 24 | 3.2% | 7.9% | ||
| Q3 24 | 16.3% | 0.4% | ||
| Q2 24 | 14.8% | -26.7% |
资本支出强度ACLSARDX
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | 0.3% | ||
| Q3 25 | 0.9% | 0.1% | ||
| Q2 25 | 1.0% | 0.7% | ||
| Q1 25 | 2.6% | 0.4% | ||
| Q4 24 | 1.8% | 0.5% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 0.8% | 0.2% |
现金转化率ACLSARDX
| Q1 26 | — | — | ||
| Q4 25 | -0.19× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.26× | 2.11× | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.79× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
